Hans Postlind
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
-
- Hormonal Regulation and Hypertension
Papers in
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 15
- Pharmacological Effects of Natural Compounds 1
-
- Hormonal Regulation and Hypertension 11
- Co-authors
- Lena Jendeberg (1 shared paper)Patrik Blomquist (1 shared paper)Kristian Svensson (1 shared paper)Rolf Ohlsson (1 shared paper)Göran Bertilsson (1 shared paper)Anders Berkenstam (1 shared paper)Kjell Wikvall (7 shared papers)Robert H. Tukey (2 shared papers)
- Journals
- Biochemical Journal (5 papers)Biochemical and Biophysical Research Communications (4 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Assay and Drug Development Technologies (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Hans Postlind
19 papers receiving 1.4k citations
Hans Postlind's Hit Papers
Peers
Comparison fields: 5 of 91
- Pharmacology 798
- Endocrinology, Diabetes and Metabolism 388
- Oncology 434
- Toxicology 36
- Genetics 283
Countries citing papers authored by Hans Postlind
This map shows the geographic impact of Hans Postlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Postlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Postlind more than expected).
Fields of papers citing papers by Hans Postlind
This network shows the impact of papers produced by Hans Postlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Postlind. The network helps show where Hans Postlind may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Postlind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction Hit paper breakdown → | 1998 | 753 |
| 2 | Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. | 2007 | 245 |
| 3 | 1993 | 134 | |
| 4 | Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. | 1998 | 85 |
| 5 | 1994 | 63 | |
| 6 | 1997 | 37 | |
| 7 | 1992 | 26 | |
| 8 | Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. | 1998 | 26 |
| 9 | 1991 | 23 | |
| 10 | 1995 | 21 | |
| 11 | 1990 | 18 | |
| 12 | 1990 | 15 | |
| 13 | 1989 | 15 | |
| 14 | 1988 | 13 | |
| 15 | 1996 | 10 | |
| 16 | 2005 | 9 | |
| 17 | 2000 | 9 | |
| 18 | 2004 | 8 | |
| 19 | 2000 | 2 |
About Hans Postlind
Hans Postlind is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Genetics and Oncology, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Hormonal Regulation and Hypertension (11 papers), Estrogen and related hormone effects (5 papers), Vitamin D Research Studies (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Diet and metabolism studies (2 papers), Muscle metabolism and nutrition (1 paper) and Pharmacological Effects of Natural Compounds (1 paper). The work is most often cited by research in Pharmacology (798 citations), Endocrinology, Diabetes and Metabolism (388 citations), Oncology (434 citations), Toxicology (36 citations) and Genetics (283 citations). Hans Postlind has collaborated with scholars based in Sweden and United States. Frequent co-authors include Lena Jendeberg, Patrik Blomquist, Kristian Svensson, Rolf Ohlsson, Göran Bertilsson, Anders Berkenstam, Kjell Wikvall, Robert H. Tukey, Paweł Baranczewski and Thai Vu. Their work appears in journals such as Biochemical Journal, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences, Journal of Pharmaceutical and Biomedical Analysis and Assay and Drug Development Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.